Myungmoon Pharmaceutical, Foreigners Net Buy 340,079 Shares... Stock Price -6.74%
Myeongmun Pharmaceutical ranked among the top searched stocks for 3 days in the past month.
As of 11:30 AM on the 23rd, Myeongmun Pharmaceutical is trading at 8,850 KRW, down 6.74% from the previous day. This represents a 43.2% increase compared to November 25. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.
Today, foreigners have a tentative net purchase of 340,079 shares of Myeongmun Pharmaceutical, and institutions have a net purchase of 29,000 shares. Over the past 5 days, individual investors have net purchased 167,291 shares, while foreigners and institutions have net sold 60,802 shares and 10,592 shares, respectively.
On December 22, Myeongmun Pharmaceutical was a market topic due to the news of sales of 'Camostat' for COVID-19 suppression, which led to an upward trend.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.